Camlipixant is an English word starting with the letter C. With 3 example sentences you'll see exactly how it works in context.
Camlipixant in a sentence
Using Camlipixant
- In the example corpus, camlipixant often appears in combinations such as: of camlipixant.
Context around Camlipixant
- Average sentence length in these examples: 20 words
- Position in the sentence: 1 start, 0 middle, 2 end
- Sentence types: 3 statements, 0 questions, 0 exclamations
Corpus analysis for Camlipixant
- In this selection, "camlipixant" usually appears near the end of the sentence. The average example has 20 words, and this corpus slice is mostly made up of statements.
- Recognizable usage signals include camlipixant a novel and formulation of camlipixant is ongoing. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "camlipixant" sits close to words such as aabc, aacr and aacsb, which helps place it inside the broader word index.
Example types with camlipixant
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
The Phase 1 clinical trial investigating the pharmacokinetics of a once daily, extended-release formulation of camlipixant is ongoing. (19 words)
With these points in mind, we’re confident that the Phase 3 program can assess the true potential of camlipixant. (20 words)
Camlipixant, a novel, highly selective P2X3 antagonist, has the potential to be a best-in-class treatment with significant sales potential. (21 words)
Camlipixant, a novel, highly selective P2X3 antagonist, has the potential to be a best-in-class treatment with significant sales potential. (21 words)
With these points in mind, we’re confident that the Phase 3 program can assess the true potential of camlipixant. (20 words)
The Phase 1 clinical trial investigating the pharmacokinetics of a once daily, extended-release formulation of camlipixant is ongoing. (19 words)
Example sentences (3)
Camlipixant, a novel, highly selective P2X3 antagonist, has the potential to be a best-in-class treatment with significant sales potential.
The Phase 1 clinical trial investigating the pharmacokinetics of a once daily, extended-release formulation of camlipixant is ongoing.
With these points in mind, we’re confident that the Phase 3 program can assess the true potential of camlipixant.
Common combinations with camlipixant
These word pairs occur most frequently in English texts:
- of camlipixant 2×